Inflammatory Processes — Anti-Inflammatory Therapy
Histopathologic studies suggest that inflammatory processes are active at sites of neurodegeneration in Alzheimer’s disease (AD) (see Aisen and Davis, 1994). Acute phase proteins such as a-1 antichymotrypsin (ACT), a-2 macroglobulin and C-reactive protein (CRP) are components of plaques. Interleukins 1 and 6, inflammatory cytokines with the capacity to stimulate expression of acute phase proteins, are present in increased amounts. In addition, early components of the complement cascade are found in the region of neuritic plaques. The cellular component of the inflammatory reaction in the AD brain appears to be the activated microglial cell. These cells bear HLA surface markers, and appear to be closely related to, perhaps derived from, blood-borne mononuclear phagocytes. Activated microglia seem to be involved in the maturation of neuritic plaques.
KeywordsPlacebo Arthritis Dementia Diarrhea Methotrexate
Unable to display preview. Download preview PDF.
- Aisen PS, Marin D, Altstiel L, Goodwin C, Baruch B, Jacobson R, Ryan T and Davis KL (1996): A pilot study of prednisone in Alzheimer’s disease. Dementia (in press).Google Scholar
- Fagarasan MO and Aisen PS (1996): IL-1 and anti-inflammatory drugs modulate Ab cytotoxicity in PC 12 cells. Brain Res (in press).Google Scholar
- Magarinos AM, Orchinik M and McEwen BS (1995): Oral administration of corticosterone mimics effects of stress on hippocampal CA3c dendritic structure. Soc for Neurosci Abstr 21:1948.Google Scholar
- Sapolsky RM, Uno H, Rebert CS et al. (1990): Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 10:1897–1902.Google Scholar